Rubius Therapeutics, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q1 2018 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Rubius Therapeutics, Inc. annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q1 2018 to Q1 2022.
  • Rubius Therapeutics, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2022 was $1.43M, a 35.2% increase year-over-year.
  • Rubius Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $4.39M, a 13.8% decline from 2021.
  • Rubius Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $5.09M, a 33.2% increase from 2020.
  • Rubius Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $3.82M, a 29.1% increase from 2019.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $1.43M +$371K +35.2% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q1 2021 $1.05M +$159K +17.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $895K +$559K +166% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-08-20
Q1 2019 $336K +$257K +325% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $79K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.